FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17468011000001107: Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60473901000001112 Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60474001000001110 Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Is a Buprenorphine 35micrograms/hour patches 4 patch true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has AMP Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has specific active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start